NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-019686 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 22, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
300,000
Total Value
$4,186,617.98
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Ordinary Shares | โ | Jan 20, 2026 | Exercise/Conversion | 60,216 | $9.26 | $557,600.16 | 118,598 | Direct | โ | View Details | |
Chief Financial Officer | Ordinary Shares | โ | Jan 20, 2026 | Sale | 900 | $30.64 | $27,576.00 | 117,698 | Direct | โ | View Details | |
Chief Financial Officer | Ordinary Shares | โ | Jan 20, 2026 | Sale | 39,712 | $31.78 | $1,262,047.36 | 77,986 | Direct | โ | View Details | |
Chief Financial Officer | Ordinary Shares | โ | Jan 20, 2026 | Sale | 19,604 | $32.38 | $634,777.52 | 58,382 | Direct | โ | View Details | |
Chief Financial Officer | Ordinary Shares | โ | Jan 21, 2026 | Exercise/Conversion | 39,784 | $9.26 | $368,399.84 | 98,166 | Direct | โ | View Details | |
Chief Financial Officer | Ordinary Shares | โ | Jan 21, 2026 | Sale | 15,422 | $33.25 | $512,781.50 | 82,744 | Direct | โ | View Details | |
Chief Financial Officer | Ordinary Shares | โ | Jan 21, 2026 | Sale | 24,362 | $33.80 | $823,435.60 | 58,382 | Direct | โ | View Details | |
Chief Financial Officer | Option (Right to Buy) | Derivative | Jan 20, 2026 | Exercise/Conversion | 60,216 | $0.00 | $0.00 | 702,598 | Direct | โ | View Details | |
Chief Financial Officer | Option (Right to Buy) | Derivative | Jan 21, 2026 | Exercise/Conversion | 39,784 | $0.00 | $0.00 | 662,814 | Direct | โ | View Details |